Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025
Between December 2024 and August 2025, two Italian HIV/STI clinics offered long-acting injectable cabotegravir (CAB-LA) for HIV prevention in 265 individuals, representing the first European real-world implementation. Participants were prioritised based on vulnerabilities compromising oral pre-expos...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
European Centre for Disease Prevention and Control
2025-10-01
|
| Серія: | Eurosurveillance |
| Предмети: | |
| Онлайн доступ: | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.39.2500739 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|